Sorry, the page you requested could not be found

Sorry that you couldn't find the page you wanted.

Here are a couple of ways that can help you find that information successfully.

Content Search:

Quote Search:

(Stocks, ETFs, Mutual Funds)

TheStreet Directory

  RealMoney.com
Dow Jones S&P 500 NASDAQ 10-Year Note
10,023.42 1,069.30 2,112.44 35.03
Oil *
76.05
UP
17.46
UP
2.67
UP
7.12
DOWN
0.30
10 Yr
3.50%
SPDR Gold
107.43
+0.17%
+0.25%
+0.34%
-0.85%
Data delayed 20 minutes

More From TheStreet

Latest Headlines

  Sorry, the page you requested could not be found

Sorry that you couldn't find the page you wanted.

Here are a couple of ways that can help you find that information successfully.

Content Search:

Quote Search:

(Stocks, ETFs, Mutual Funds)

TheStreet Directory

Dow Jones S&P 500 NASDAQ 10-Year Note
10,023.42 1,069.30 2,112.44 35.03
Oil *
76.05
UP
17.46
UP
2.67
UP
7.12
DOWN
0.30
10 Yr
3.50%
SPDR Gold
107.43
+0.17%
+0.25%
+0.34%
-0.85%
Data delayed 20 minutes


Commentary: This Week in IPOs
*New* Alerts! Please click here...

The Accenture IPO: So Far, So Good
By Ben Holmes
New Issues Editor

7/19/01 2:34 PM ET



Having trouble finding someone who likes the new Accenture (ACN:NYSE - news - commentary) IPO? Well, look no further than this column, because I am your man. I like its business, I like its competitive posture (the client list is breathtaking) and I love its financials. Check out what I wrote on Sunday for a quick rundown on Accenture's most recent results.

Who Says Size Doesn't Matter?

Last night Goldman Sachs priced 115 million shares of Accenture at $14.50 in what is the fourth-largest IPO of the year. As I write this piece, ACN is trading up about 60 cents at $15.12. Not a high-octane burner, but by no means a failure, either. Remember, this was 115 million shares and, in an IPO market, that's clearly a bit wobbly.

Ironically, the Accenture deal unseats rival KPMG Consulting (KCIN:Nasdaq - news - commentary) from the No. 4 spot. KPMG went public in February at $18 and, after a short-lived premium, has been bumbling along at a $14 share price. The difference between the two is profitability -- Accenture's got it, KPMG doesn't.

Off to a Good Start

Looking at today's performance of Accenture and comparing it with the initial performance of KPMG (which traded up nearly 30% in its first session), you have to believe that rationality is gaining a toehold in this IPO market and that now, more than ever, comps are very important. A soft-start performance like this bodes well for the near-term future of Accenture because, unlike KPMG, there isn't an overhang of burned investors who will stand on the issue with sell orders and dampen the stock's advancement.

By the Way

In what looks to be a tug-down-the-britches dig at big-name accounting consultancy IPOs, Deloitte Consulting bought up page A9 of today's Wall Street Journal to display an ad that simply reads, "Deloitte Consulting is pleased not to announce an IPO." With the valuations of these firms being clearly established by Wall Street, I wonder just how long Deloitte will hold out.

Ben Holmes' IPO data are available at www.ipopros.com. The site includes a complete and forward-looking calendar, as well as a complete record of deals and links to important SEC documents.

Click on www.ipopros.com for your free 2 week trial.


Ben Holmes is the founder of ipoPros.com, a Boulder, Colo.-based research boutique (now a wholly-owned subsidiary of TheStreet.com) specializing in the analysis of equity syndicate offerings. This column is not meant as investment advice; it is instead meant to provide insight into the methods of new and secondary offerings. Neither Holmes nor his firm has entered indications of interest in any of the companies discussed in this column. Holmes' This Week in IPOs column appears Sundays, This Week's Secondaries appears Tuesdays, Upcoming Lockup Expirations appears Wednesdays and The Quiet Period appears on Fridays. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Holmes appreciates your feedback and invites you to send it to Ben Holmes.
Send letters to the editor to letters@realmoney.com.
Read our conflicts and disclosure policy.
Order reprints of RealMoney.com articles. Top

Research Now
on CSFBdirect
ACN KICN
Get a FREE Handspring™ Visor™ from CSFBdirect.

RELATED STORIES


This Week in IPOs
Keep Your Powder Dry and Stay Tuned
7/15/01 4:51 PM ET
This week: Technology consultant Accenture and medical devices manufacturer Natus Medical.

This Week in IPOs
No IPO Column Today
6/25/01 4:05 PM ET

This Week in IPOs
Nothing to Get Excited About in This Week's IPOs
6/18/01 4:59 PM ET
Don't force things. You don't have to trade every week.




Apply now for a CSFBdirect account ONLINE INVESTING
Get a FREE Handspring™ Visor™ from CSFBdirect.
BANKING
Get a $50 bonus from NetBank.





Click to change or update chart Click to change or update chart Click to change or update chart

WorldInvestorTile

Sorry, the page you requested could not be found

Sorry that you couldn't find the page you wanted.

Here are a couple of ways that can help you find that information successfully.

Content Search:

Quote Search:

(Stocks, ETFs, Mutual Funds)

TheStreet Directory

Dow Jones S&P 500 NASDAQ 10-Year Note
10,023.42 1,069.30 2,112.44 35.03
Oil *
76.05
UP
17.46
UP
2.67
UP
7.12
DOWN
0.30
10 Yr
3.50%
SPDR Gold
107.43
+0.17%
+0.25%
+0.34%
-0.85%
Data delayed 20 minutes